BioRestorative Therapies, a Melvillve, NY-based company that develops stem cell therapies, has applied for listing on the Nasdaq under the ticker symbol "BRTX."
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $1.40 |
|---|---|
| 52-week range | $1.03 - $3.67 |
| 50-day moving average | $1.63 |
| 200-day moving average | $1.54 |
| Wall St. target price | $13.00 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-0.87 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $1.39 from 2024-11-19
| 1 week (2024-11-13) | -9.74% |
|---|---|
| 1 month (2024-10-18) | -16.52% |
| 3 months (2024-08-20) | -16.61% |
| 6 months (2024-05-20) | 7.75% |
| 1 year (2023-11-20) | -22.78% |
|---|---|
| 2 years (2022-11-18) | -50.36% |
| 3 years (2021-11-19) | 6.85 |
| 5 years (2019-11-20) | 228 |
| Revenue TTM | $377,000 |
|---|---|
| Gross profit TTM | $119,800 |
| Return on assets TTM | -53.24% |
| Return on equity TTM | -17.12% |
| Profit margin | 0% |
| Book value | $1.44 |
| Market Capitalization | $10 million |
TTM: trailing 12 months
We're not expecting BioRestorative Therapies to pay a dividend over the next 12 months.
You may also wish to consider:
BioRestorative Therapies's shares were split on a 1:4000 basis on 26 October 2021 . So if you had owned 4000 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your BioRestorative Therapies shares – just the quantity. However, indirectly, the new 399900% higher share price could have impacted the market appetite for BioRestorative Therapies shares which in turn could have impacted BioRestorative Therapies's share price.
Over the last 12 months, BioRestorative Therapies's shares have ranged in value from as little as $1.03 up to $3.6699. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BioRestorative Therapies's is 62.823. This would suggest that BioRestorative Therapies's shares are significantly more volatile than the average for this exchange and represent a higher risk.
To put BioRestorative Therapies's beta into context you can compare it against those of similar companies.
BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells. The company develops programs relate to the treatment of disc/spine disease and metabolic disorders. Its products pipeline comprises BRTX-100, a lead cell therapy candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, as well as used for the non-surgical treatment of painful lumbosacral disc disorders or as a complimentary therapeutic to a surgical procedure; and ThermoStem, a cell-based therapy candidate to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. The company also provides investigational curved needle device to deliver cells and/or other therapeutic products or material to the spine and discs, and other parts of the body. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co.
Robinhood Launches Presidential Election Event Contracts Ahead of the Nov 5 Presidential Election
Explore the best bonuses for opening a new brokerage account.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Compare pros, cons, research tools and reviews for these two trading platforms.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
What you need to know about investing in the leading indicator for the overall US stock market.
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
A deep dive into the highlights and limitations of Robinhood.